Cordlife Group Past Earnings Performance
Past criteria checks 2/6
Cordlife Group has been growing earnings at an average annual rate of 3%, while the Healthcare industry saw earnings growing at 15.1% annually. Revenues have been declining at an average rate of 2.5% per year. Cordlife Group's return on equity is 2.8%, and it has net margins of 6.6%.
Key information
3.0%
Earnings growth rate
2.8%
EPS growth rate
Healthcare Industry Growth | 9.7% |
Revenue growth rate | -2.5% |
Return on equity | 2.8% |
Net Margin | 6.6% |
Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Cordlife Group Limited (SGX:P8A) Looks Inexpensive After Falling 30% But Perhaps Not Attractive Enough
May 06Risks Still Elevated At These Prices As Cordlife Group Limited (SGX:P8A) Shares Dive 31%
Mar 22Estimating The Fair Value Of Cordlife Group Limited (SGX:P8A)
Sep 07Cordlife Group (SGX:P8A) Will Be Hoping To Turn Its Returns On Capital Around
Aug 02Cordlife Group (SGX:P8A) Might Be Having Difficulty Using Its Capital Effectively
Apr 03Cordlife Group (SGX:P8A) Is Looking To Continue Growing Its Returns On Capital
Oct 15Cordlife Group's (SGX:P8A) Problems Go Beyond Weak Profit
Aug 22Revenue & Expenses BreakdownBeta
How Cordlife Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 23 | 56 | 4 | 38 | 0 |
30 Sep 23 | 57 | 4 | 38 | 0 |
30 Jun 23 | 57 | 5 | 38 | 0 |
31 Mar 23 | 56 | 5 | 37 | 0 |
31 Dec 22 | 55 | 5 | 36 | 0 |
30 Sep 22 | 55 | 5 | 36 | 0 |
30 Jun 22 | 56 | 6 | 35 | 0 |
31 Mar 22 | 56 | 6 | 36 | 0 |
31 Dec 21 | 57 | 6 | 36 | 0 |
30 Sep 21 | 58 | 6 | 36 | 0 |
30 Jun 21 | 60 | 6 | 37 | 0 |
31 Mar 21 | 60 | 6 | 37 | 0 |
31 Dec 20 | 59 | 7 | 38 | 0 |
30 Sep 20 | 59 | 8 | 39 | 0 |
30 Jun 20 | 58 | 7 | 41 | 0 |
31 Mar 20 | 58 | 7 | 42 | 0 |
31 Dec 19 | 62 | 6 | 43 | 0 |
30 Sep 19 | 60 | 3 | 43 | 0 |
30 Jun 19 | 59 | 2 | 43 | 0 |
31 Mar 19 | 69 | 4 | 43 | 0 |
31 Dec 18 | 60 | 2 | 44 | 0 |
30 Jun 18 | 68 | 3 | 43 | 0 |
31 Mar 18 | 67 | 3 | 42 | 0 |
31 Dec 17 | 62 | -1 | 40 | 0 |
30 Sep 17 | 62 | -1 | 40 | 0 |
30 Jun 17 | 60 | -3 | 39 | 0 |
31 Mar 17 | 60 | -6 | 41 | 0 |
31 Dec 16 | 60 | -7 | 40 | 0 |
30 Sep 16 | 60 | 4 | 39 | 0 |
30 Jun 16 | 60 | 12 | 38 | 0 |
31 Mar 16 | 60 | 36 | 37 | 0 |
31 Dec 15 | 59 | 56 | 36 | 0 |
30 Sep 15 | 59 | 43 | 36 | 0 |
30 Jun 15 | 58 | 32 | 35 | 0 |
31 Mar 15 | 56 | 28 | 32 | 0 |
31 Dec 14 | 53 | 11 | 31 | 0 |
30 Sep 14 | 51 | 18 | 29 | 0 |
30 Jun 14 | 49 | 31 | 27 | 0 |
31 Mar 14 | 45 | 18 | 25 | 0 |
31 Dec 13 | 40 | 18 | 23 | 0 |
30 Sep 13 | 37 | 19 | 20 | 0 |
30 Jun 13 | 35 | 13 | 18 | 0 |
Quality Earnings: P8A has high quality earnings.
Growing Profit Margin: P8A's current net profit margins (6.6%) are lower than last year (8.9%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: P8A's earnings have grown by 3% per year over the past 5 years.
Accelerating Growth: P8A's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: P8A had negative earnings growth (-24%) over the past year, making it difficult to compare to the Healthcare industry average (-2%).
Return on Equity
High ROE: P8A's Return on Equity (2.8%) is considered low.